- Approval Id
- 0eb4f8eee3fe5270
- Drug Name
- LASIX TABLET 40 mg
- Product Name
- LASIX TABLET 40 mg
- Approval Number
- SIN00199P
- Approval Date
- 1988-03-28
- Registrant
- SANOFI-AVENTIS SINGAPORE PTE. LTD.
- Licence Holder
- SANOFI-AVENTIS SINGAPORE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- TABLET
- Dosage
- **Dosage**
In general, the dose used must be the lowest which is sufficient to achieve the desired effect.
Unless otherwise prescribed, the following dosage guidelines apply:
In adults, treatment is usually started with 1/2–1–2 tablets daily; the maintenance dose is 1/2–1 tablet daily.
In infants and children, Lasix should in principle be administered orally. The dosage recommendation is 2 mg furosemide per kg body weight up to a daily maximum of 40 mg.
Parenteral administration (if necessary, continuous drip infusion) is indicated only in life-threatening conditions.
- Route Of Administration
- ORAL
- Indication Info
- **Indications**
Oedema due to cardiac, hepatic, or renal disorders (in the presence of nephrotic syndrome, treatment of the basic disorder is the prime concern). Oedema due to burns. Mild to moderate hypertension.
- Contraindications
- **Contraindications**
Lasix must not be used in patients with:
- renal failure accompanied by lack of urine formation (anuria) in patients not responding to furosemide
- hepatic coma and precoma
- severely reduced blood levels of potassium (hypokalaemia – see Adverse Reaction – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_), or of sodium (hyponatraemia)
- decreased volume of blood in the body (hypovolaemia) – with or without reduced blood pressure (hypotension) – or dehydration
- hypersensitivity to furosemide or any of the excipients (see “Composition” – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Patients allergic to sulphonamides (e.g. sulphonamide antibiotics or sulphonylureas) may show cross-sensitivity to furosemide.
- lactation
- Atc Code
- C03CA01
- Atc Item Name
- furosemide
- Pharma Manufacturer Name
- SANOFI-AVENTIS SINGAPORE PTE. LTD.
- Company Detail Path
- /organization/sanofi-aventis-singapore-pte-ltd
